Home NDC 50845-0266 Candida Yeast
Product NDC 50845-0266
11-digit product format 508450266
Labeler code 50845
Product ID 50845-0266_87f447b1-2229-491d-a61e-631d4b03a7c6
Type HUMAN OTC DRUG
Nonproprietary name Baptisia Tinctoria, Borax, Candida Albicans, Candida Parapsilosis, Cinchona Officinalis, Echinacea (Angustifolia), Nitricum Acidum, Pulsatilla (Pratensis), Pyrogenium, Sepia, Sulphuricum Acidum, Thuja Occidentalis
Dosage form SPRAY
Route ORAL
Labeler Liddell Laboratories, Inc.
Marketing category UNAPPROVED HOMEOPATHIC
Marketing start 2020-03-18
Marketing end 2025-03-26
Substance ANEMONE PRATENSIS; BAPTISIA TINCTORIA ROOT; CANDIDA ALBICANS; CANDIDA PARAPSILOSIS; CINCHONA OFFICINALIS BARK; ECHINACEA ANGUSTIFOLIA WHOLE; NITRIC ACID; RANCID BEEF; SEPIA OFFICINALIS JUICE; SODIUM BORATE; SULFURIC ACID; THUJA OCCIDENTALIS LEAFY TWIG
Active strength 30 [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL
Pharmacologic classes Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]
NDC exclude flag No
Listing certified through 0000-00-00
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 8 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Dataset, Scope table Captured / source date Dataset Scope Package NDC Code Status Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 excluded product product D Discontinued by firm d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 50845-0266-1 D Discontinued by firm d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 excluded product product D Discontinued by firm f5e01cc5f278…a2eaf40c39c3…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 50845-0266-1 D Discontinued by firm f5e01cc5f278…a2eaf40c39c3…2022-04-09 23:13 UTC · source 2022-04-08 excluded product product I Inactivated by FDA 86f5da6cb304…a595104c45d7…2022-04-09 23:13 UTC · source 2022-04-08 excluded package package 50845-0266-1 I Inactivated by FDA 86f5da6cb304…a595104c45d7…2022-04-04 05:40 UTC · source 2022-04-01 excluded product product I Inactivated by FDA bd6a592717d7…303034d00443…2022-04-04 05:40 UTC · source 2022-04-01 excluded package package 50845-0266-1 I Inactivated by FDA bd6a592717d7…303034d00443…
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
FDA-Initiated Inactive NDC Indexing# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 50845-0266-1 50845026601 30 mL in 1 BOTTLE, SPRAY (50845-0266-1) 30 ml 2020-03-18 0000-00-00 No No Current